Diclofenac topical formulation
US8871809B2 · kind B2 · utility
4Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2013 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Sep 12, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.